Bacitracin
Back to searchMolecule Structure
Scientific Name
Bacitracin
Description of the Drug
Bacitracin is a cyclic polypeptide antibiotic used to prevent wound infections, treat pneumonia and empyema in infants, and to treat skin and eye infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00626
http://www.drugbank.ca/drugs/DB00626
Brand Name(s)
Albac 50, Baciferm 50, Baciguent, Baciim, Baci-rx, Bacitracin
Company Owner(s)
Glaxosmithkline, Bausch And Lomb Pharmaceuticals Inc, Xellia Pharmaceuticals Aps, Mylan Asi Llc, Akorn Operating Co Llc, Altana Inc, Casper Pharma Llc, Fresenius Kabi Usa Llc, Monarch Pharmaceuticals Inc, Eli Lilly And Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| C55-isoprenyl pyrophosphate | SMALL MOLECULE | INHIBITOR | CHEMBL2364036 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL20385900 | |||
| Human Metabolome Database | HMDB0014764 | |||
| DrugBank | DB00626 | |||
| PubChem: Thomson Pharma | 15958136 | 26514780 | ||
| PubChem | 10909430 | |||
| NMRShiftDB | 70011378 | |||
| Nikkaji | J286.255G | |||
| BindingDB | 50458054 | |||
| rxnorm | BACIGUENT | BACITRACIN | BACITRACIN ZINC | BACITRACIN A |
| KEGG Ligand | C15482 | |||
| ChEBI | 35862 | 184381 |
